불면장애 진단과 치료의 최신 지견
Recent Advances in Diagnosis and Treatment of Insomnia Disorder
1
조회
0
다운로드
18
인용
0
참고문헌
키워드
초록
The diagnostic concepts of insomnia are controversial. New diagnostic criteria of insomnia disorder have been published in the International Classification of Sleep Disorders (ICSD-3) and the Diagnostic and Statistical Manual of Mental Disorder (DSM-5). Both the ICSD-3 and DSM-5 did not accept the concept of secondary and primary insomnia. According to the ICSD-3 and DSM- 5, insomnia disorder can be diagnosed, even with a comorbid mental or sleep disorder. The medical, psychiatric, and sleep history are essential for the diagnosis of insomnia disorder. Polysomnography can be helpful for differential diagnoses or the clinical subtyping of insomnia disorder. Recently, the European and American Sleep Society published clinical guidelines for the treatment of insomnia. Both guidelines strongly recommended non-pharmacological treatment (e.g., cognitive behavioral disorder for insomnia) as a treatment of choice for insomnia. Pharmacological treatments for insomnia are weakly recommended only for a short time. New non-pharmacological and pharmacological treatments for insomnia disorder are being developed and studied.
Abstract
The diagnostic concepts of insomnia are controversial. New diagnostic criteria of insomnia disorder have been published in the International Classification of Sleep Disorders (ICSD-3) and the Diagnostic and Statistical Manual of Mental Disorder (DSM-5). Both the ICSD-3 and DSM-5 did not accept the concept of secondary and primary insomnia. According to the ICSD-3 and DSM- 5, insomnia disorder can be diagnosed, even with a comorbid mental or sleep disorder. The medical, psychiatric, and sleep history are essential for the diagnosis of insomnia disorder. Polysomnography can be helpful for differential diagnoses or the clinical subtyping of insomnia disorder. Recently, the European and American Sleep Society published clinical guidelines for the treatment of insomnia. Both guidelines strongly recommended non-pharmacological treatment (e.g., cognitive behavioral disorder for insomnia) as a treatment of choice for insomnia. Pharmacological treatments for insomnia are weakly recommended only for a short time. New non-pharmacological and pharmacological treatments for insomnia disorder are being developed and studied.
참고문헌 (76)
- American Academy of Sleep Medicine, "International classification of sleep disorders" (2014), American Academy of Sleep Medicine
- American Psychiatry Association, "Diagnostic and statistical manual of mental disorders" (2013), American Psychaitry Association
- Sateia MJ, "Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults : an American Academy of Sleep Medicine clinical practice guideline", J Clin Sleep Med, 13, pp.307~349 (2017)
- Riemann D, "European guideline for the diagnosis and treatment of insomnia", J Sleep Res, 26, pp.675~700 (2017)
- American Academy of Sleep Medicine, "International classification of sleep disorders, revised: diagnostic and coding manual" (2001), American Academy of Sleep Medicine
- Castelnovo A, "The paradox of paradoxical insomnia: a theoretical review towards a unifying evidence-based definition", Sleep Med Rev, 44, pp.70~82 (2019)
- Krystal AD, "NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes", Sleep, 25, pp.630~640 (2002)
- Rezaie L, "Paradoxical insomnia and subjective-objective sleep discrepancy: a review", Sleep Med Rev, 40, pp.196~202 (2018)
- Vgontzas AN, "Insomnia with objective short sleep duration : the most biologically severe phenotype of the disorder", Sleep Med Rev, 17, pp.241~254 (2013)
- Fernandez-Mendoza J, "The insomnia with short sleep duration phenotype:an update on it’s importance for health and prevention", Curr Opin Psychiatry, 30, pp.56~63 (2017)
- Benjamins JS, "Insomnia heterogeneity : characteristics to consider for data-driven multivariate subtyping", Sleep Med Rev, 36, pp.71~81 (2017)
- Galbiati A, "Impact of phenotypic heterogeneity of insomnia on the patients’ response to Cognitive-Behavioral Therapy for Insomnia : current perspectives", Nat Sci Sleep, 11, pp.367~376 (2019)
- Schutte-Rodin S, "Clinical guideline for the evaluation and management of chronic insomnia in adults", J Clin Sleep Med, 4, pp.487~504 (2008)
- Benca RM, "Reconsidering insomnia as a disorder rather than just a symptom in psychiatric practice", J Clin Psychiatry, 79 (2018)
- Currie SR, "Comprehensive assessment of insomnia in recovering alcoholics using daily sleep diaries and ambulatory monitoring", Alcohol Clin Exp Res, 27, pp.1262~1269 (2003)
- Morgenthaler T, "An american academy of sleep medicine report", Sleep, 29, pp.1415~1419 (2006)
- Cheung JMY, "Cognitive behavioral therapies for insomnia and hypnotic medications : considerations and controversies", Sleep Med Clin, 14, pp.253~265 (2019)
- Edinger JD, "Cognitive behavioral therapy for treatment of chronic primary insomnia : a randomized controlled trial", JAMA, 285, pp.1856~1864 (2001)
- Morin CM, "Behavioral and pharmacological therapies for late-life insomnia : a randomized controlled trial", JAMA, 281, pp.991~999 (1999)
- Bjorvatn B, "The association between insomnia and bedroom habits and bedroom characteristics : an exploratory cross-sectional study of a representative sample of adults", Sleep Health, 4, pp.188~193 (2018)
- van der Zweerde T, "Cognitive behavioral therapy for insomnia : a meta-analysis of longterm effects in controlled studies", Sleep Med Rev, 48, pp.101208~ (2019)
- Thakral M, "Changes in dysfunctional beliefs about sleep after cognitive behavioral therapy for insomnia : a systematic literature review and metaanalysis", Sleep Med Rev, 49, pp.101230~ (2019)
- Boland E, "Precision medicine for insomnia", Sleep Med Clin, 14, pp.291~299 (2019)
- Drerup ML, "Online delivery of cognitive behavioral therapy-insomnia : considerations and controversies", Sleep Med Clin, 14, pp.283~290 (2019)
- Buenaver LF, "Delivering cognitive behavioral therapy for insomnia in the real world : considerations and controversies", Sleep Med Clin, 14, pp.275~281 (2019)
- Arnedt JT, "Randomized controlled trial of telephone-delivered cognitive behavioral therapy for chronic insomnia", Sleep, 36, pp.353~362 (2013)
- Ritterband LM, "Effect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up : a randomized clinical trial", JAMA Psychiatry, 74, pp.68~75 (2017)
- Luik AI, "Digital delivery of cognitive behavioral therapy for insomnia", Curr Psychiatry Rep, 21, pp.50~ (2019)
- Seyffert M, "Internet-delivered cognitive behavioral therapy to treat insomnia : a systematic review and meta-analysis", PLoS One, 11, pp.e0149139~ (2016)
- Salvemini A, "Insomnia and information and communication technologies (ICT) in elderly people: a systematic review", Med Sci (Basel), 7, pp.70~ (2019)
- Buysse DJ, "Efficacy of brief behavioral treatment for chronic insomnia in older adults", Arch Intern Med, 171, pp.887~895 (2011)
- Gunn HE, "Brief behavioral treatment of insomnia", Sleep Med Clin, 14, pp.235~243 (2019)
- Troxel WM, "Predictors of treatment response to brief behavioral treatment of insomnia(BBTI)in older adults", J Clin Sleep Med, 9, pp.1281~1289 (2013)
- Ellis JG, "Cognitive behavioral therapy for insomnia and acute insomnia : considerations and controversies", Sleep Med Clin, 14, pp.267~274 (2019)
- Lack L, "Intensive sleep retraining treatment of insomnia", Sleep Med Clin, 14, pp.245~252 (2019)
- Rash JA, "A meta-analysis of mindfulness-based therapies for insomnia and sleep disturbance : moving towards processes of change", Sleep Med Clin, 14, pp.209~233 (2019)
- Melo DLM, "Biofeedback therapies for chronic insomnia : a systematic review", Appl Psychophysiol Biofeedback, 44, pp.259~269 (2019)
- Schabus M, "Better than sham? A double-blind placebo-controlled neurofeedback study in primary insomnia", Brain, 140, pp.1041~1052 (2017)
- Huang Z, "Repetitive transcranial magnetic stimulation of the right parietal cortex for comorbid generalized anxiety disorder and insomnia: a randomized, double-blind, sham-controlled pilot study", Brain Stimul, 11, pp.1103~1109 (2018)
- Jiang CG, "Efficacy of repetitive transcranial magnetic stimulation in the treatment of patients with chronic primary insomnia", Cell Biochem Biophys, 67, pp.169~173 (2013)
- Wilt TJ, "Pharmacologic treatment of insomnia disorder : an evidence report for a clinical practice guideline by the American College of Physicians", Ann Intern Med, 165, pp.103~112 (2016)
- Gerlach LB, "Prescription benzodiazepine use among older adults : a critical review", Harv Rev Psychiatry, 26, pp.264~273 (2018)
- Wong CK, "Spontaneous adverse event reports associated with zolpidem in the United States 2003-2012", J Clin Sleep Med, 13, pp.223~234 (2017)
- Lee J, "Use of sedative-hypnotics and the risk of Alzheimer’s dementia : a retrospective cohort study", PLoS One, 13, pp.e0204413~ (2018)
- Pillai V, "Effectiveness of benzodiazepine receptor agonists in the treatment of insomnia : an examination of response and remission rates", Sleep, 40 (2017)
- By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel, "American Geriatrics Society 2015 Updated Beers Criteria for potentially inappropriate medication use in older adults", J Am Geriatr Soc, 63, pp.2227~2246 (2015)
- Hintze JP, "Hypnotic discontinuation in chronic insomnia", Sleep Med Clin, 13, pp.263~270 (2018)
- Beaulieu-Bonneau S, "Long-term main-tenance of therapeutic gains associated with cognitive-behavioral therapy for insomnia delivered alone or combined with zolpidem", Sleep, 40, pp.zsx002~ (2017)
- Winkler A, "Effect of placebo conditions on polysomnographic parameters in primary insomnia: a meta-analysis", Sleep, 38, pp.925~931 (2015)
- Takaesu Y, "Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: a systematic review and meta-analysis", Sleep Med Rev, 48, pp.101214~ (2019)
- Auld F, "Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders", Sleep Med Rev, 34, pp.10~22 (2017)
- Wade A, "Prolonged-release melatonin for the treatment of insomnia in patients over 55 years", Expert Opin Investig Drugs, 17, pp.1567~1572 (2008)
- Riha RL, "The use and misuse of exogenous melatonin in the treatment of sleep disorders", Curr Opin Pulm Med, 24, pp.543~548 (2018)
- Sys J, "Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review", Eur J Clin Pharmacol (2019)
- Frase L, "Making sleep easi-er: pharmacological interventions for insomnia", Expert Opin Pharmacother, 19, pp.1465~1473 (2018)
- Everitt H, "Antidepressants for insomnia in adults", Cochrane Database Syst Rev, 5, pp.CD010753~ (2018)
- Karsten J, "Low doses of mir-tazapine or quetiapine for transient insomnia: a randomised, doubleblind, cross-over, placebo-controlled trial", J Psychopharmacol, 31, pp.327~337 (2017)
- Ruwe F, "A phase 2 randomized dose-finding study with esmirtazapine in patients with primary insomnia", J Clin Psychopharmacol, 36, pp.457~464 (2016)
- Srinivasan V, "Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hyp-notics?", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.913~923 (2011)
- Yi XY, "Trazodone for the treatment of insomnia: a meta-analysis of random-ized placebo-controlled trials", Sleep Med, 45, pp.25~32 (2018)
- Merenstein D, "The trial of infant response to diphenhydramine: the TIRED study--a randomized, controlled, patient-oriented trial", Arch Pediatr Adolesc Med, 160, pp.707~712 (2006)
- Hoyer D, "Hypnotics with novel modes of ac-tion", Br J Clin Pharmacol (2019)
- Raglan GB, "Cognitive behavioral therapy for insomnia in patients with medical and psychiatric comorbidities", Sleep Med Clin, 14, pp.167~175 (2019)
- Gebara MA, "Effect of insomnia treatments on depression: a systematic review and meta-analysis", Depress Anxiety, 35, pp.717~731 (2018)
- Asarnow LD, "Cognitive behavioral therapy for insomnia in depression", Sleep Med Clin, 14, pp.177~184 (2019)
- Blom K, "Three-year fol-low-up comparing cognitive behavioral therapy for depression to cognitive behavioral therapy for insomnia, for patients with both di-agnoses", Sleep, 40, pp.zsx108~ (2017)
- Fava M, "Eszopiclone co-administered with fluoxetine in patients with insom-nia coexisting with major depressive disorder", Biol Psychiatry, 59, pp.1052~1060 (2006)
- Colvonen PJ, "Recent advancements in treating sleep disorders in co-occurring PTSD", Curr Psychiatry Rep, 20, pp.48~ (2018)
- Akinnusi M, "Drug treatment strategies for insomnia in patients with post-traumatic stress disorder", Expert Opin Pharmaco-ther, 20, pp.691~699 (2019)
- Kaplan KA, "Behavioral treatment of insomnia in bipolar disorder", Am J Psychiatry, 170, pp.716~720 (2013)
- Glidewell RN, "Insomnia and anxiety:diagnostic and management implications of complex interactions", Sleep Med Clin, 10, pp.93~99 (2015)
- Uhde TW, "Anxiety and sleep problems:emerging concepts and theoretical treatment implications", Curr Psy-chiatry Rep, 11, pp.269~276 (2009)
- Al-Jawder SE, "Comorbid insomnia in sleep-related breathing disorders: an under-recognized association", Sleep Breath, 16, pp.295~304 (2012)
- Sweetman A, "Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: a randomized clin-ical trial", Sleep, 42, pp.zsz178~ (2019)
- Gupta R, "When insomnia is not just insomnia: the deeper correlates of disturbed sleep with reference to DSM-5", Asian J Psy-chiatr, 12, pp.23~30 (2014)
- Miller MA, "Sleep pharmacotherapy for common sleep disorders in pregnancy and lactation", Chest, 157, pp.184~197 (2020)
